LLY: כמות מזומנים למניה Eli Lilly and Company

The cash per share chart for Eli Lilly and Company (LLY) on GURU.Markets shows an upward trend, where the value 5.14 describes the current liquidity level. The automation of drug synthesis via neural networks is driving this growth. Exclusive patents in diabetes therapy form the foundation of profits, while the high cost of innovative drugs amid colossal demand guarantees the company a stable cash generator.
פילוחים אנליטיים של חברת Eli Lilly and Company

This ratio reflects the relationship between net liquidity and the number of common shares, allowing for an assessment of the internal financial reserve per share. By analyzing the calculated cash per share, an investor can see how expenditures on synthesis robotization and neural network molecule discovery at Eli Lilly and Company (LLY) impact the company's margin of safety, determining the stability of its investment profile.